APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Imaging Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Diagnostic Imaging Agent Industry Growth and Trends Forecast to 2032

Report ID 173902880125 December 2025103 pages

Choose your research edition.

Industry ResearchDiagnostic Imaging Agent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Imaging Agent Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Imaging Agent Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Imaging Agent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Diagnostic Imaging Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diagnostic Imaging Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diagnostic Imaging Agent market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diagnostic Imaging Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diagnostic Imaging Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diagnostic Imaging Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diagnostic Imaging Agent Market by Company

GE HealthCare

Bracco Diagnostic

Guerbet

Abx Advanced Biochemical

Bayer AG

Blue Earth Diagnostics

Cardinal Health

Eli Lilly and Company

Lantheus

Mallinckrodt

Navidea

Yantai Dongcheng

Foshan Rui Diao Pharmaceutical

Jubilant Pharma Limited

Diagnostic Imaging Agent Segment by Type

Conjugated Imaging Agent

Metabolic Imaging Agent

Blood Flow and Blood Volume Imaging Agents

Diagnostic Imaging Agent Segment by Application

Neurological Disease

Gastrointestinal Disease

Heart Disease

Tumor

Diagnostic Imaging Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Conjugated Imaging Agent Table 2. Major Company of Metabolic Imaging Agent Table 3. Major Company of Blood Flow and Blood Volume Imaging Agents Table 4. Global Diagnostic Imaging Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 6. Global Diagnostic Imaging Agent Sales Market Share in Volume by Type (2021-2026) Table 7. Global Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 8. Global Diagnostic Imaging Agent Sales Market Share in Value by Type (2021-2026) Table 9. Global Diagnostic Imaging Agent Price by Type (2021-2026) & (US$/Unit) Table 10. Global Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 11. Global Diagnostic Imaging Agent Sales Market Share in Volume by Type (2027-2032) Table 12. Global Diagnostic Imaging Agent Sales by Type (2027-2032) & (US$ Million) Table 13. Global Diagnostic Imaging Agent Sales Market Share in Value by Type (2027-2032) Table 14. Global Diagnostic Imaging Agent Price by Type (2027-2032) & (US$/Unit) Table 15. North America Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 16. North America Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 18. Europe Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 22. Latin America Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Diagnostic Imaging Agent Sales by Type (2021-2026) & (US$ Million) Table 25. Diagnostic Imaging Agent Industry Trends Table 26. Diagnostic Imaging Agent Industry Drivers Table 27. Diagnostic Imaging Agent Industry Opportunities and Challenges Table 28. Diagnostic Imaging Agent Industry Restraints Table 29. Global Diagnostic Imaging Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Diagnostic Imaging Agent Revenue Market Share by Company (2021-2026) Table 31. Global Diagnostic Imaging Agent Sales by Company (2021-2026) & (K Units) Table 32. Global Diagnostic Imaging Agent Sales Share by Company (2021-2026) Table 33. Global Diagnostic Imaging Agent Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Diagnostic Imaging Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Diagnostic Imaging Agent Major Company Production Sites and Headquarters Table 36. Global Diagnostic Imaging Agent Company, Product Type & Application Table 37. Global Diagnostic Imaging Agent Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Diagnostic Imaging Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Diagnostic Imaging Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Diagnostic Imaging Agent Sales by Region (2021-2026) & (K Units) Table 42. Global Diagnostic Imaging Agent Sales Market Share in Volume by Region (2021-2026) Table 43. Global Diagnostic Imaging Agent Sales by Region (2021-2026) & (US$ Million) Table 44. Global Diagnostic Imaging Agent Sales Market Share in Value by Region (2021-2026) Table 45. Global Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Diagnostic Imaging Agent Sales by Region (2027-2032) & (K Units) Table 47. Global Diagnostic Imaging Agent Sales Market Share in Volume by Region (2027-2032) Table 48. Global Diagnostic Imaging Agent Sales by Region (2027-2032) & (US$ Million) Table 49. Global Diagnostic Imaging Agent Sales Market Share in Value by Region (2027-2032) Table 50. Global Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Diagnostic Imaging Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 53. Global Diagnostic Imaging Agent Sales Market Share in Volume by Application (2021-2026) Table 54. Global Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 55. Global Diagnostic Imaging Agent Sales Market Share in Value by Application (2021-2026) Table 56. Global Diagnostic Imaging Agent Price by Application (2021-2026) & (US$/Unit) Table 57. Global Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 58. Global Diagnostic Imaging Agent Sales Market Share in Volume by Application (2027-2032) Table 59. Global Diagnostic Imaging Agent Sales by Application (2027-2032) & (US$ Million) Table 60. Global Diagnostic Imaging Agent Sales Market Share in Value by Application (2027-2032) Table 61. Global Diagnostic Imaging Agent Price by Application (2027-2032) & (US$/Unit) Table 62. North America Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 63. North America Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 65. Europe Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 69. Latin America Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Diagnostic Imaging Agent Sales by Application (2021-2026) & (US$ Million) Table 72. GE HealthCare Company Information Table 73. GE HealthCare Business Overview Table 74. GE HealthCare Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GE HealthCare Diagnostic Imaging Agent Product Portfolio Table 76. GE HealthCare Recent Development Table 77. Bracco Diagnostic Company Information Table 78. Bracco Diagnostic Business Overview Table 79. Bracco Diagnostic Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio Table 81. Bracco Diagnostic Recent Development Table 82. Guerbet Company Information Table 83. Guerbet Business Overview Table 84. Guerbet Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Guerbet Diagnostic Imaging Agent Product Portfolio Table 86. Guerbet Recent Development Table 87. Abx Advanced Biochemical Company Information Table 88. Abx Advanced Biochemical Business Overview Table 89. Abx Advanced Biochemical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio Table 91. Abx Advanced Biochemical Recent Development Table 92. Bayer AG Company Information Table 93. Bayer AG Business Overview Table 94. Bayer AG Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bayer AG Diagnostic Imaging Agent Product Portfolio Table 96. Bayer AG Recent Development Table 97. Blue Earth Diagnostics Company Information Table 98. Blue Earth Diagnostics Business Overview Table 99. Blue Earth Diagnostics Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio Table 101. Blue Earth Diagnostics Recent Development Table 102. Cardinal Health Company Information Table 103. Cardinal Health Business Overview Table 104. Cardinal Health Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cardinal Health Diagnostic Imaging Agent Product Portfolio Table 106. Cardinal Health Recent Development Table 107. Eli Lilly and Company Company Information Table 108. Eli Lilly and Company Business Overview Table 109. Eli Lilly and Company Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio Table 111. Eli Lilly and Company Recent Development Table 112. Lantheus Company Information Table 113. Lantheus Business Overview Table 114. Lantheus Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Lantheus Diagnostic Imaging Agent Product Portfolio Table 116. Lantheus Recent Development Table 117. Mallinckrodt Company Information Table 118. Mallinckrodt Business Overview Table 119. Mallinckrodt Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Mallinckrodt Diagnostic Imaging Agent Product Portfolio Table 121. Mallinckrodt Recent Development Table 122. Navidea Company Information Table 123. Navidea Business Overview Table 124. Navidea Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Navidea Diagnostic Imaging Agent Product Portfolio Table 126. Navidea Recent Development Table 127. Yantai Dongcheng Company Information Table 128. Yantai Dongcheng Business Overview Table 129. Yantai Dongcheng Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio Table 131. Yantai Dongcheng Recent Development Table 132. Foshan Rui Diao Pharmaceutical Company Information Table 133. Foshan Rui Diao Pharmaceutical Business Overview Table 134. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio Table 136. Foshan Rui Diao Pharmaceutical Recent Development Table 137. Jubilant Pharma Limited Company Information Table 138. Jubilant Pharma Limited Business Overview Table 139. Jubilant Pharma Limited Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio Table 141. Jubilant Pharma Limited Recent Development Table 142. North America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 144. North America Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 145. North America Diagnostic Imaging Agent Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Diagnostic Imaging Agent Sales Market Share Forecast by Country (2027-2032) Table 147. North America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Diagnostic Imaging Agent Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Diagnostic Imaging Agent Market Share by Country (2021-2026) Table 150. North America Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Diagnostic Imaging Agent Market Share Forecast by Country (2027-2032) Table 152. Europe Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 154. Europe Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 155. Europe Diagnostic Imaging Agent Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Diagnostic Imaging Agent Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Diagnostic Imaging Agent Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Diagnostic Imaging Agent Market Share by Country (2021-2026) Table 160. Europe Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Diagnostic Imaging Agent Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Diagnostic Imaging Agent Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Diagnostic Imaging Agent Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Diagnostic Imaging Agent Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Diagnostic Imaging Agent Market Share by Country (2021-2026) Table 170. Asia-Pacific Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Diagnostic Imaging Agent Market Share Forecast by Country (2027-2032) Table 172. Latin America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 174. Latin America Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 175. Latin America Diagnostic Imaging Agent Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Diagnostic Imaging Agent Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Diagnostic Imaging Agent Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Diagnostic Imaging Agent Market Share by Country (2021-2026) Table 180. Latin America Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Diagnostic Imaging Agent Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Diagnostic Imaging Agent Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Diagnostic Imaging Agent Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Diagnostic Imaging Agent Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Diagnostic Imaging Agent Market Share by Country (2021-2026) Table 190. Middle East and Africa Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Diagnostic Imaging Agent Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Diagnostic Imaging Agent Distributors List Table 195. Diagnostic Imaging Agent Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Diagnostic Imaging Agent Image Figure 2. Global Diagnostic Imaging Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Imaging Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Imaging Agent Sales (2021-2032) & (K Units) Figure 5. Conjugated Imaging Agent Image Figure 6. Global Conjugated Imaging Agent Sales YoY Growth (2021-2032) & (K Units) Figure 7. Metabolic Imaging Agent Image Figure 8. Global Metabolic Imaging Agent Sales YoY Growth (2021-2032) & (K Units) Figure 9. Blood Flow and Blood Volume Imaging Agents Image Figure 10. Global Blood Flow and Blood Volume Imaging Agents Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Diagnostic Imaging Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Diagnostic Imaging Agent Market Share by Type 2025 VS 2032 Figure 13. North America Diagnostic Imaging Agent Sales Market Share in Volume by Type in 2025 Figure 14. North America Diagnostic Imaging Agent Sales Market Share in Value by Type in 2025 Figure 15. Europe Diagnostic Imaging Agent Sales Market Share in Volume by Type in 2025 Figure 16. Europe Diagnostic Imaging Agent Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Diagnostic Imaging Agent Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Diagnostic Imaging Agent Sales Market Share in Value by Type in 2025 Figure 19. Latin America Diagnostic Imaging Agent Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Diagnostic Imaging Agent Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Diagnostic Imaging Agent Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Diagnostic Imaging Agent Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Diagnostic Imaging Agent Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Neurological Disease Image Figure 26. Global Neurological Disease Sales YoY Growth (2021-2032) & (K Units) Figure 27. Gastrointestinal Disease Image Figure 28. Global Gastrointestinal Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Heart Disease Image Figure 30. Global Heart Disease Sales YoY Growth (2021-2032) & (K Units) Figure 31. Tumor Image Figure 32. Global Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Diagnostic Imaging Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Diagnostic Imaging Agent Market Share by Application 2025 VS 2032 Figure 35. North America Diagnostic Imaging Agent Sales Market Share in Volume by Application in 2025 Figure 36. North America Diagnostic Imaging Agent Sales Market Share in Value by Application in 2025 Figure 37. Europe Diagnostic Imaging Agent Sales Market Share in Volume by Application in 2025 Figure 38. Europe Diagnostic Imaging Agent Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Diagnostic Imaging Agent Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Diagnostic Imaging Agent Sales Market Share in Value by Application in 2025 Figure 41. Latin America Diagnostic Imaging Agent Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Diagnostic Imaging Agent Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Diagnostic Imaging Agent Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Diagnostic Imaging Agent Sales Market Share in Value by Application in 2025 Figure 45. North America Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Diagnostic Imaging Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Diagnostic Imaging Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Diagnostic Imaging Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Diagnostic Imaging Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Diagnostic Imaging Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Diagnostic Imaging Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Diagnostic Imaging Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Diagnostic Imaging Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Diagnostic Imaging Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Diagnostic Imaging Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Diagnostic Imaging Agent Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Diagnostic Imaging Agent Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Conjugated Imaging Agent
  • Metabolic Imaging Agent
  • Blood Flow and Blood Volume Imaging Agents
Applications
  • Neurological Disease
  • Gastrointestinal Disease
  • Heart Disease
  • Tumor
Companies covered
  • GE HealthCare
  • Bracco Diagnostic
  • Guerbet
  • Abx Advanced Biochemical
  • Bayer AG
  • Blue Earth Diagnostics
  • Cardinal Health
  • Eli Lilly and Company
  • Lantheus
  • Mallinckrodt
  • Navidea
  • Yantai Dongcheng
  • Foshan Rui Diao Pharmaceutical
  • Jubilant Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diagnostic Imaging Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diagnostic Imaging Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diagnostic Imaging Agent Market by Type
  6. 1.3.1 Conjugated Imaging Agent
  7. 1.3.2 Metabolic Imaging Agent
  8. 1.3.3 Blood Flow and Blood Volume Imaging Agents
  9. 1.4 Global Diagnostic Imaging Agent Market Size by Type
  10. 1.4.1 Global Diagnostic Imaging Agent Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Diagnostic Imaging Agent Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Diagnostic Imaging Agent Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Diagnostic Imaging Agent Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Diagnostic Imaging Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Diagnostic Imaging Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Diagnostic Imaging Agent Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Diagnostic Imaging Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diagnostic Imaging Agent Industry Trends
  2. 2.2 Diagnostic Imaging Agent Industry Drivers
  3. 2.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
  4. 2.4 Diagnostic Imaging Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diagnostic Imaging Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Diagnostic Imaging Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Diagnostic Imaging Agent Price (2021-2026)
  4. 3.4 Global Diagnostic Imaging Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diagnostic Imaging Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Diagnostic Imaging Agent Company, Product Type & Application
  7. 3.7 Global Diagnostic Imaging Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diagnostic Imaging Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diagnostic Imaging Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diagnostic Imaging Agent Tier 1, Tier 2, and Tier 3
4 Diagnostic Imaging Agent Regional Status and Outlook
  1. 4.1 Global Diagnostic Imaging Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diagnostic Imaging Agent Historic Market Size by Region
  3. 4.2.1 Global Diagnostic Imaging Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diagnostic Imaging Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diagnostic Imaging Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diagnostic Imaging Agent Forecasted Market Size by Region
  7. 4.3.1 Global Diagnostic Imaging Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diagnostic Imaging Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diagnostic Imaging Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diagnostic Imaging Agent by Application
  1. 5.1 Diagnostic Imaging Agent Market by Application
  2. 5.1.1 Neurological Disease
  3. 5.1.2 Gastrointestinal Disease
  4. 5.1.3 Heart Disease
  5. 5.1.4 Tumor
  6. 5.2 Global Diagnostic Imaging Agent Market Size by Application
  7. 5.2.1 Global Diagnostic Imaging Agent Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Diagnostic Imaging Agent Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Diagnostic Imaging Agent Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Diagnostic Imaging Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Diagnostic Imaging Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Diagnostic Imaging Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Diagnostic Imaging Agent Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Diagnostic Imaging Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GE HealthCare
  2. 6.1.1 GE HealthCare Company Information
  3. 6.1.2 GE HealthCare Business Overview
  4. 6.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
  6. 6.1.5 GE HealthCare Recent Developments
  7. 6.2 Bracco Diagnostic
  8. 6.2.1 Bracco Diagnostic Company Information
  9. 6.2.2 Bracco Diagnostic Business Overview
  10. 6.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
  12. 6.2.5 Bracco Diagnostic Recent Developments
  13. 6.3 Guerbet
  14. 6.3.1 Guerbet Company Information
  15. 6.3.2 Guerbet Business Overview
  16. 6.3.3 Guerbet Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
  18. 6.3.5 Guerbet Recent Developments
  19. 6.4 Abx Advanced Biochemical
  20. 6.4.1 Abx Advanced Biochemical Company Information
  21. 6.4.2 Abx Advanced Biochemical Business Overview
  22. 6.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
  24. 6.4.5 Abx Advanced Biochemical Recent Developments
  25. 6.5 Bayer AG
  26. 6.5.1 Bayer AG Company Information
  27. 6.5.2 Bayer AG Business Overview
  28. 6.5.3 Bayer AG Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
  30. 6.5.5 Bayer AG Recent Developments
  31. 6.6 Blue Earth Diagnostics
  32. 6.6.1 Blue Earth Diagnostics Company Information
  33. 6.6.2 Blue Earth Diagnostics Business Overview
  34. 6.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
  36. 6.6.5 Blue Earth Diagnostics Recent Developments
  37. 6.7 Cardinal Health
  38. 6.7.1 Cardinal Health Company Information
  39. 6.7.2 Cardinal Health Business Overview
  40. 6.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
  42. 6.7.5 Cardinal Health Recent Developments
  43. 6.8 Eli Lilly and Company
  44. 6.8.1 Eli Lilly and Company Company Information
  45. 6.8.2 Eli Lilly and Company Business Overview
  46. 6.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
  48. 6.8.5 Eli Lilly and Company Recent Developments
  49. 6.9 Lantheus
  50. 6.9.1 Lantheus Company Information
  51. 6.9.2 Lantheus Business Overview
  52. 6.9.3 Lantheus Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
  54. 6.9.5 Lantheus Recent Developments
  55. 6.10 Mallinckrodt
  56. 6.10.1 Mallinckrodt Company Information
  57. 6.10.2 Mallinckrodt Business Overview
  58. 6.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
  60. 6.10.5 Mallinckrodt Recent Developments
  61. 6.11 Navidea
  62. 6.11.1 Navidea Company Information
  63. 6.11.2 Navidea Business Overview
  64. 6.11.3 Navidea Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
  66. 6.11.5 Navidea Recent Developments
  67. 6.12 Yantai Dongcheng
  68. 6.12.1 Yantai Dongcheng Company Information
  69. 6.12.2 Yantai Dongcheng Business Overview
  70. 6.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
  72. 6.12.5 Yantai Dongcheng Recent Developments
  73. 6.13 Foshan Rui Diao Pharmaceutical
  74. 6.13.1 Foshan Rui Diao Pharmaceutical Company Information
  75. 6.13.2 Foshan Rui Diao Pharmaceutical Business Overview
  76. 6.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
  78. 6.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
  79. 6.14 Jubilant Pharma Limited
  80. 6.14.1 Jubilant Pharma Limited Company Information
  81. 6.14.2 Jubilant Pharma Limited Business Overview
  82. 6.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
  84. 6.14.5 Jubilant Pharma Limited Recent Developments
7 North America by Country
  1. 7.1 North America Diagnostic Imaging Agent Sales by Country
  2. 7.1.1 North America Diagnostic Imaging Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diagnostic Imaging Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Diagnostic Imaging Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diagnostic Imaging Agent Market Size by Country
  6. 7.2.1 North America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diagnostic Imaging Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diagnostic Imaging Agent Sales by Country
  2. 8.1.1 Europe Diagnostic Imaging Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diagnostic Imaging Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Diagnostic Imaging Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diagnostic Imaging Agent Market Size by Country
  6. 8.2.1 Europe Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diagnostic Imaging Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diagnostic Imaging Agent Sales by Country
  2. 9.1.1 Asia-Pacific Diagnostic Imaging Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diagnostic Imaging Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diagnostic Imaging Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diagnostic Imaging Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diagnostic Imaging Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diagnostic Imaging Agent Sales by Country
  2. 10.1.1 South America Diagnostic Imaging Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diagnostic Imaging Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Diagnostic Imaging Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diagnostic Imaging Agent Market Size by Country
  6. 10.2.1 South America Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diagnostic Imaging Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diagnostic Imaging Agent Sales by Country
  2. 11.1.1 Middle East and Africa Diagnostic Imaging Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diagnostic Imaging Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diagnostic Imaging Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diagnostic Imaging Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Diagnostic Imaging Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diagnostic Imaging Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diagnostic Imaging Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diagnostic Imaging Agent Value Chain Analysis
  2. 12.1.1 Diagnostic Imaging Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diagnostic Imaging Agent Production Mode & Process
  7. 12.2 Diagnostic Imaging Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diagnostic Imaging Agent Distributors
  10. 12.2.3 Diagnostic Imaging Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst